Becton Dickinson & Co
American multinational medical technology company
BDX NYSE
SEC CIK 10795
Follow Becton Dickinson
Weekly email: filings, results, news
Revenue, last quarter
$5B
+5.4% vs same quarter last year
Net income
$377M
−34.3% vs same quarter last year
EPS, diluted
$1.37
−31.5% vs same quarter last year
Operating cash flow
$776M
−28.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $21.8B | $1.7B |
| FY24 | $20.2B | $1.7B |
| FY23 | $19.4B | $1.5B |
| FY22 | $18.9B | $1.8B |
| FY21 | $19.1B | $2.1B |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 11.8% | 7.7% |
| FY24 | 11.9% | 8.4% |
| FY23 | 10.9% | 7.7% |
| FY22 | 12.1% | 9.4% |
| FY21 | 11.8% | 10.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $2.7B |
| FY24 | $3.1B |
| FY23 | $2.1B |
| FY22 | $1.5B |
| FY21 | $3.5B |
- Becton Dickinson
- Healthcare median
Show the numbers
| Year | Becton Dickinson | Healthcare median |
|---|---|---|
| FY25 | 7.7% | 9.8% |
| FY24 | 8.4% | 10.5% |
| FY23 | 7.7% | 5.3% |
| FY22 | 9.4% | 12.7% |
| FY21 | 10.9% | 10.8% |